scispace - formally typeset
M

Melody Diamond

Researcher at GlaxoSmithKline

Publications -  15
Citations -  1206

Melody Diamond is an academic researcher from GlaxoSmithKline. The author has contributed to research in topics: Cell growth & Phosphoinositide 3-kinase. The author has an hindex of 10, co-authored 15 publications receiving 1124 citations. Previous affiliations of Melody Diamond include DuPont.

Papers
More filters
Journal ArticleDOI

Human mdm2 Mediates Multiple Mono-ubiquitination of p53 by a Mechanism Requiring Enzyme Isomerization *

TL;DR: It is shown that the multistep cascade of mdm2-mediated p53 ubiquitination can be reduced to three purified recombinant proteins: ubiquitin-conjugated E2, mDM2, and p53, and it is found that p53 is modified with multiple mono-ubiquitin moieties as opposed to a poly-ubsin chain.
Journal ArticleDOI

Differentiation of Hdm2-mediated p53 ubiquitination and Hdm2 autoubiquitination activity by small molecular weight inhibitors

TL;DR: These compounds establish the feasibility of selectively blocking hdm2-mediated ubiquitination of p53 by small molecule inhibitors, and provide a novel mechanism for the development of new chemotherapeutics for the treatment of human cancers.
Journal ArticleDOI

Distinct Concentration-Dependent Effects of the Polo-like Kinase 1-Specific Inhibitor GSK461364A,Including Differential Effect on Apoptosis

TL;DR: A potent, selective, reversible, ATP-competitive inhibitor of Plk1, GSK461364A, capable of inhibiting cell growth of most proliferating cancer cell lines tested is identified and observed.